检索结果 - Kantarjian

Refine Results
  1. 1
    Acute myeloid leukemia—Major progress over four decades and glimpses into the future

    Acute myeloid leukemia—Major progress over four decades and glimpses into the future 由 Hagop Kantarjian

    出版 2015
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  2. 2
    Honoring Emil J. Freireich: A Visionary Medical Cancer Researcher—March 21, 1927–February 1, 2021

    Honoring Emil J. Freireich: A Visionary Medical Cancer Researcher—March 21, 1927–February 1, 2021 由 Kantarjian, Hagop M.

    出版 2021
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  3. 3
    The development of dasatinib as a treatment for chronic myeloid leukemia (CML): from initial studies to application in newly diagnosed patients

    The development of dasatinib as a treatment for chronic myeloid leukemia (CML): from initial studies to application in newly diagnosed patients 由 Andreas Hochhaus, Hagop Kantarjian

    出版 2013
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  4. 4
    The development of dasatinib as a treatment for chronic myeloid leukemia (CML): from initial studies to application in newly diagnosed patients

    The development of dasatinib as a treatment for chronic myeloid leukemia (CML): from initial studies to application in newly diagnosed patients 由 Hochhaus, Andreas, Kantarjian, Hagop

    出版 2013
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  5. 5
    How I treat newly diagnosed chronic phase CML

    How I treat newly diagnosed chronic phase CML 由 Cortes, Jorge, Kantarjian, Hagop

    出版 2012
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  6. 6
    Considerations in the Management of Patients With Philadelphia Chromosome–Positive Chronic Myeloid Leukemia Receiving Tyrosine Kinase Inhibitor Therapy

    Considerations in the Management of Patients With Philadelphia Chromosome–Positive Chronic Myeloid Leukemia Receiving Tyrosine Kinase Inhibitor Therapy 由 Kantarjian, Hagop, Cortes, Jorge

    出版 2011
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  7. 7
    TARGETED THERAPY: Generic imatinib — impact on frontline and salvage therapy for CML

    TARGETED THERAPY: Generic imatinib — impact on frontline and salvage therapy for CML 由 Gorkin, Larry, Kantarjian, Hagop

    出版 2016
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  8. 8
    Immunotherapy in adult acute lymphoblastic leukemia: the role of monoclonal antibodies

    Immunotherapy in adult acute lymphoblastic leukemia: the role of monoclonal antibodies 由 Jabbour, Elias, Kantarjian, Hagop

    出版 2016
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  9. 9
    Chronic myeloid leukemia: sequencing of TKI therapies

    Chronic myeloid leukemia: sequencing of TKI therapies 由 Cortes, Jorge, Kantarjian, Hagop

    出版 2016
    获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  10. 10
    Core binding factor acute myelogenous leukemia-2021 treatment algorithm

    Core binding factor acute myelogenous leukemia-2021 treatment algorithm 由 Borthakur, Gautam, Kantarjian, Hagop

    出版 2021
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  11. 11
    Acute lymphoblastic leukemia a comprehensive review with emphasis on biology and therapy

    Acute lymphoblastic leukemia a comprehensive review with emphasis on biology and therapy 由 Jorge E. Cortés, H. Kantarjian

    出版 1995
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  12. 12
    Chronic myeloid leukemia: 2018 update on diagnosis, therapy and monitoring

    Chronic myeloid leukemia: 2018 update on diagnosis, therapy and monitoring 由 Elias Jabbour, Hagop M. Kantarjian

    出版 2018
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  13. 13
    Chronic myeloid leukemia: 2020 update on diagnosis, therapy and monitoring

    Chronic myeloid leukemia: 2020 update on diagnosis, therapy and monitoring 由 Elias Jabbour, Hagop M. Kantarjian

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  14. 14
    Core binding factor acute myelogenous leukemia-2021 treatment algorithm

    Core binding factor acute myelogenous leukemia-2021 treatment algorithm 由 Gautam Borthakur, Hagop M. Kantarjian

    出版 2021
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  15. 15
    Moving toward individualized target-based therapies in acute myeloid leukemia

    Moving toward individualized target-based therapies in acute myeloid leukemia 由 Alexandre Bazinet, Hagop M. Kantarjian

    出版 2022
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  16. 16
    Chronic myeloid leukemia: 2025 update on diagnosis, therapy, and monitoring

    Chronic myeloid leukemia: 2025 update on diagnosis, therapy, and monitoring 由 Elias Jabbour, Hagop M. Kantarjian

    出版 2024
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  17. 17
    When Less Is More: Reevaluating the Role of Intensive Chemotherapy for Older Adults With Acute Myeloid Leukemia in the Modern Era

    When Less Is More: Reevaluating the Role of Intensive Chemotherapy for Older Adults With Acute Myeloid Leukemia in the Modern Era 由 Short, Nicholas J., Kantarjian, Hagop

    出版 2021
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  18. 18
    How I treat newly diagnosed chronic phase CML

    How I treat newly diagnosed chronic phase CML 由 Jorge E. Cortés, Hagop M. Kantarjian

    出版 2012
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  19. 19
    Impact of Cancer Research Bureaucracy on Innovation, Costs, and Patient Care

    Impact of Cancer Research Bureaucracy on Innovation, Costs, and Patient Care 由 David P. Steensma, Hagop M. Kantarjian

    出版 2014
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  20. 20
    Navigating the Management of Chronic Phase CML in the Era of Generic BCR::ABL1 Tyrosine Kinase Inhibitors

    Navigating the Management of Chronic Phase CML in the Era of Generic BCR::ABL1 Tyrosine Kinase Inhibitors 由 Fadi G. Haddad, Hagop M. Kantarjian

    出版 2024
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: